FRACTYL HEALTH/$GUTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About FRACTYL HEALTH
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Ticker
$GUTS
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
109
ISIN
US35168W1036
Website
FRACTYL HEALTH Metrics
BasicAdvanced
$90M
-
-$1.84
-
-
Price and volume
Market cap
$90M
52-week high
$7.89
52-week low
$0.87
Average daily volume
287K
Financial strength
Current ratio
2.502
Quick ratio
2.24
Long term debt to equity
885.224
Total debt to equity
963.529
Management effectiveness
Return on assets (TTM)
-49.05%
Return on equity (TTM)
-196.81%
Valuation
Price to revenue (TTM)
1,482.675
Price to book
14.12
Price to tangible book (TTM)
14.12
Price to free cash flow (TTM)
-1.111
Growth
Revenue change (TTM)
-59.46%
Earnings per share change (TTM)
-80.04%
3-year earnings per share growth (CAGR)
-60.98%
What the Analysts think about FRACTYL HEALTH
Analyst ratings (Buy, Hold, Sell) for FRACTYL HEALTH stock.
FRACTYL HEALTH Financial Performance
Revenues and expenses
FRACTYL HEALTH Earnings Performance
Company profitability
FRACTYL HEALTH News
AllArticlesVideos
Fractyl Health Advances Rejuva® Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes
GlobeNewsWire·3 days ago
Fractyl Health Unveils New Rejuva® Smart GLP-1™ Pancreatic Gene Therapy Preclinical Data Highlighting Durable Potency and Safety with Limited Systemic GLP-1 Exposure at ASGCT 2025
GlobeNewsWire·5 days ago
Forge Biologics Announces AAV Development and cGMP Manufacturing Relationship with Fractyl Health to Advance Their Gene Therapy Platform for Patients with Metabolic Diseases
Business Wire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for FRACTYL HEALTH stock?
FRACTYL HEALTH (GUTS) has a market cap of $90M as of May 22, 2025.
What is the P/E ratio for FRACTYL HEALTH stock?
The price to earnings (P/E) ratio for FRACTYL HEALTH (GUTS) stock is 0 as of May 22, 2025.
Does FRACTYL HEALTH stock pay dividends?
No, FRACTYL HEALTH (GUTS) stock does not pay dividends to its shareholders as of May 22, 2025.
When is the next FRACTYL HEALTH dividend payment date?
FRACTYL HEALTH (GUTS) stock does not pay dividends to its shareholders.
What is the beta indicator for FRACTYL HEALTH?
FRACTYL HEALTH (GUTS) does not currently have a Beta indicator.